Coronary Artery Bypass Grafting

ACUITY: Acute Catheterization and Urgent Intervention Triage Strategy Trial

      -Implications of Preoperative Thienopyridine Use Prior to CABG by Dr. Ramin Ebrahimi (TCT 2006)

AFIST III: Atrial Fibrillation Suppressions Trial III

      -Impact of Epicardial Anterior Fat Pad Retention on Postcardiothoracic Surgery Atrial Fibrillation Incidence by C. Michael White, PharmD

ART: Randomized Trial to Compare Bilateral Versus Single Internal Mammary Coronary Artery Bypass Grafting (CABG)

      -One-Year Results of the Arterial Revascularization Trial by Dr. David P. Taggart (ESC 2010)

 

ARTS-2: Arterial Revascularization Therapies Study Part II

      -A Non-randomized Comparison of Contemporary PCI and CABG in Patients with Multi-Vessel Coronary Artery Lesions (ACC 2005)

BARI 2D: Bypass Angioplasty Revascularization Investigation In Type 2 Diabetics

      -Trial Overview

CABG Risk Score  

      -A risk score for predicting who will need CABG among ACS pts. by Dr. Sai Sadanandan et al

CORONARY: The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study

      -Trial Overview by Dr. Andre Lamy (ACC 2012)

COX 2 Inhibition

      -Safety of Cyclooxygenase-2 (COX-2) Inhibitors, Valdecoxib and Parecoxib, versus Placebo for Post CABG Pain Management by Dr. Andrew Whelton

FREEDOM: Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease

      -Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease by Dr. Michael Farkouh (TCT 2008)

      -Main Results by Dr. Valentin Fuster (AHA 2012)

      -Cost-Effectiveness of PCI with Drug Eluting Stents versus Bypass Surgery for Patients with Diabetes and Multi-vessel Coronary Artery Disease by Dr. Elizabeth A. Magnuson (AHA 2012)

ISAR-CABG: Randomized, Superiority Trial of Drug-Eluting-Stent and Bare Metal Stent in Safenous Vein Graft Lesions

      -Trial Overview by Dr. Julinda Mehilli (ACC 2011)

 

ISAR Left Main Study: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

      -Trial Overview by Dr. J. Mehilli

 

Randomized Comparison of Percutaneous Coronary Intervention with Sirolimus-Eluting Stents versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis

      -Trial Overview by Dr. Enno Boudriot (CRT 2011)

 

RAPS: Radial Artery and Saphenous Vein Patency More than Five Years Following Coronary Artery Bypass Surgery

      -Trial Results by Dr. Stephen Fremes (ACC 2011)

STICH: Surgical Treatment of Ischemic Heart Failure

      -Quality of Life and Economic Outcomes with Surgical Ventricular Reconstruction in Symptomatic Heart Failure by Dr. Daniel B. Mark (ACC 2009)

    -Medical Therapy with or without Coronary Artery Bypass Graft Surgery in Patients with Ischemic Cardiomyopathy: Results of the Surgical Treatment of Ischemic Heart Failure Trial by Dr. Eric J. Velazquez (ACC 2011)

     -Influence of Myocardial Viability on Outcome of Patients with Coronary Artery Disease and Left Ventricular Dysfunction Undergoing Medical Therapy with and without Surgical Revascularization by Dr. Daniel B. Mark (ACC 2011)

SYNTAX: Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery

      -The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study Primary Endpoint Results at One Year in the Randomized Cohort by Dr. Patrick W. Serruys and Dr. Friedrich W. Mohr

      -The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries by Dr. Patrick W. Serruys and Dr. Friedrich W. Mohr

 

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster